NCT06464237Recrutement en cours
Metacognitive Intervention in Youth With Oncological Disease - the Mio Study
Résumé
The aim of the Mio-Study is to address the current lack of effective treatment options to reduce cognitive and physical long-term problems in children and adolescents with cancer. Through the use of the Mio-App, cognitive and physical development will be strengthened and metacognitive thinking and awareness will increase. The Mio-App for children and adolescence with cancer will include a combination of cognitive and physical training tasks and prospective as well as retrospective metacognitive questions. In a randomized controlled trial, the App will be analysed for its efficacy on metacognitive thinking and executive functions. In particular, the investigators are interested in factors that affect the efficacy of the training program such as compliance, age, sex or the presence of fatigue. This study will give insight into the role of metacognition in cognitive and physical performance and will foster the development of children and adolescents with cancer in the long-term.
Critères d'inclusion
• Informed consent as documented by signature (see Informed Consent Form) of participants and / or parents / legal guardians • Age 8-16 years • A diagnosis of cancer either with or without CNS involvement. The participant will be included between 3 months before to 10 years after termination of treatment. • Treatment of cancer including either radiation, chemotherapy and/ or surgical tumor removal • German or French speaking
Critères d'exclusion
• Any other instable neurological condition (e.g. epilepsy) • A severe psychiatric disease (e.g., eating disorder) or severe learning disability • Known or suspected non-compliance • Drug or alcohol abuse • Inability to follow the procedures of the study, e.g. due to language problems • Enrolment of the investigator, his/her family members, employees and other dependent persons
Contacts
Les coordonnées de l'équipe de l'essai s'affichent sur demande.
Voir la fiche officielle de l'essai- Statut
- Recrutement en cours
- Phase
- Sans phase (N/A)
- Type d'étude
- Interventionnelle
- Pays
- Suisse
- Promoteur
- Insel Gruppe AG, University Hospital Bern(Autre)
- N° de protocole
- BASEC2023-01196
- Pathologies
- Cancer
- Interventions
- Comportemental
Traitements évalués
- Mio-App
Collaborateurs
University of Bern
Lieux · 1
- Bern, SuisseInsespital, University Hospital BernRecrute dans ce centre
Au total, dans le monde, le seul centre listé au registre recrute.
Statut par centre selon le registre ClinicalTrials.gov (dernière mise à jour publiée : 26 novembre 2025).
Ce statut peut avoir changé et ne dit rien de votre éligibilité : avant toute démarche, vérifiez avec votre oncologue ou le centre.
Voir aussi
Autres versions
Ces résultats sont indicatifs et ne remplacent pas un avis médical — à discuter avec votre médecin.